Aopeng Medical Completes ￥100M Series A Financing

According to VCBeat, Shanghai Aopeng Medical Technology Co., Ltd ("Aopeng Medical"), a company specializing in endovascular interventional robots, recently announced the completion of a ￥100 million financing. Proceeds from the latest round will mainly be used to conduct clinical trials in humans, develop hardware and software, and obtain CE marking. 

Less than three years since its establishment, Aopeng Medical has successfully obtained three rounds of financing.

Founded in 2017, Aopeng Medical focuses on the R&D and manufacturing of surgical robots. Its products are mainly based on high-end manufacturing, artificial intelligence (AI), 5G and other concepts of endovascular interventional robots. Those surgical robots can be widely used in coronary intervention, neurointerventional surgery, peripheral vascular intervention, interventional surgery of tumors, and so on.

With nearly 10 years of forward-looking research, Aopeng Medical has developed the endovascular interventional robot which can be generally used. In combination with robotic technology and AI, the robot can provide the analysis of condition, surgical planning, semi-automatic and fully automatic surgery, and give the possibility to remotely do cerebrovascular surgery.

At present, Aopeng Medical has completed in vitro tests and animal tests. The surgeon operated the robotic system on the main operating table by manipulating two hand poles. During the operation, the catheter and guidewire were delivered and rotated smoothly and stably, and the surgeries in the coronary artery and peripheral artery were successful.

In the future, with the development of AI, 5G and other technologies, Aopeng medical will continue to optimize the existing robotic system, upgrade its products and realize the remote operation of vascular surgery, and facilitate the construction of classification diagnosis and treatment system.

If the vascular interventional surgical robot independently developed by Aopeng Medical is successfully applied in clinics, it will greatly alleviate the shortage of high-quality interventional medical resources in minimally invasive diagnosis and treatment, and narrow the clinical technology gap between large hospitals and small hospitals in China. On the other hand, the company has also developed surgical robots used in other departments by virtue of existing technologies.